跳至主要内容
临床试验/EUCTR2009-014268-20-NL
EUCTR2009-014268-20-NL进行中(未招募)不适用

VZV vaccination to prevent herpes zoster after transplantation - Vaccination to prevent herpes zoster

Erasmus MC0 个研究点目标入组 80 人开始时间: 2009年7月21日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Erasmus MC
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age of patient and donor is 50 years or older
  • - Patients on waitinglist for living-related kidney transplantation and their donors
  • - Patients at least 1 month prior to to kidney transplantation
  • - Patient is VZV seropositive before vaccination
  • - Patient is capable of understanding the purpose and risks of the study, fully informed and given written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Use of immunosuppresion (inhalation corticosteroids are allowed)
  • - Neomycine allergy
  • - Immunodeficiency due to e.g. acute/chronic, lymphoma or HIV
  • - Active tuberculosis

研究者

发起方
Erasmus MC

相似试验

VZV vaccination to prevent herpes zoster after... | 临床试验